Related references
Note: Only part of the references are listed.Signaling cross-talk between TGF-beta/BMP and other pathways
Xing Guo et al.
CELL RESEARCH (2009)
Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo
Xuyu Zhou et al.
NATURE IMMUNOLOGY (2009)
ERK5/MAPK is activated by TGFβ in hepatocytes and required for the GSK-3β-mediated Snail protein stabilization
Alessandra Marchetti et al.
CELLULAR SIGNALLING (2008)
Axin and GSK3-beta control Smad3 protein stability and modulate TGF-beta signaling
Xing Guo et al.
GENES & DEVELOPMENT (2008)
Novel Regulation of Vascular Endothelial Growth Factor-A (VEGF-A) by Transforming Growth Factor β1 REQUIREMENT FOR Smads, β-CATENIN, AND GSK3β
Rachel L. Clifford et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells
Yi Ding et al.
NATURE MEDICINE (2008)
Natural and TGF-β-induced Foxp3+CD4+ CD25+ regulatory T cells are not mirror images of each other
David A. Horwitz et al.
TRENDS IN IMMUNOLOGY (2008)
Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer
Yukiko Tone et al.
NATURE IMMUNOLOGY (2008)
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Jeong M. Kim et al.
NATURE IMMUNOLOGY (2007)
d Glycogen synthase kinase-3β inhibitors protect against the organ injury and dysfunction caused by hemorrhage and resuscitation
L Dugo et al.
SHOCK (2006)
Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1
U Maurer et al.
MOLECULAR CELL (2006)
Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies
H Nakashima et al.
ACTA NEUROPATHOLOGICA (2005)
Inducing and expanding regulatory T cell populations by foreign antigen
K Kretschmer et al.
NATURE IMMUNOLOGY (2005)
GSK-3β inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat
Laura Dugo et al.
CRITICAL CARE MEDICINE (2005)
Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3
M Martin et al.
NATURE IMMUNOLOGY (2005)
Erk associates with and primes GSK-3β for its inactivation resulting in upregulation of β-catenin
QQ Ding et al.
MOLECULAR CELL (2005)
Regulatory T cells in immunologic self-tolerance and autoimmune disease
S Sakaguchi et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2005)
Cutting edge:: TGF-β induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7
MC Fantini et al.
JOURNAL OF IMMUNOLOGY (2004)
CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-β suppress a stimulatory graft-versus-host disease with a lupus-like syndrome
SG Zheng et al.
JOURNAL OF IMMUNOLOGY (2004)
Wnt target genes identified by DNA microarrays in immature CD34+ thymocytes regulate proliferation and cell adhesion
FJT Staal et al.
JOURNAL OF IMMUNOLOGY (2004)
Acquisition of anergic and suppressive activities in transforming growth factor-β-costimulated CD4+CD25- T cells
HB Park et al.
INTERNATIONAL IMMUNOLOGY (2004)
CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion
MAC de Lafaille et al.
JOURNAL OF IMMUNOLOGY (2004)
Natural and induced CD4+CD25+ cells educate CD4+D25-cells to develop suppressive activity:: The role of IL-2, TGF-β, and IL-10
SG Zheng et al.
JOURNAL OF IMMUNOLOGY (2004)
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
WJ Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Control of immune homeostasis by naturally arising regulatory CD4+ T cells
M Gavin et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo
DB Ring et al.
DIABETES (2003)
Deletion of beta-catenin impairs T cell development
YY Xu et al.
NATURE IMMUNOLOGY (2003)
beta-Catenin expression in thymocytes accelerates thymic involution
YY Xu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (falfa) rats
GW Cline et al.
DIABETES (2002)
The β-catenin-TCF-I pathway ensures CD4+CD8+ thymocyte survival
V Ioannidis et al.
NATURE IMMUNOLOGY (2001)
Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc
JW Neal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3
T Ohteki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
